+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
Generic Central Nervous System Drugs Market Report 2025 - Product Thumbnail Image

Generic Central Nervous System Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Insulin Biosimilars Market Report 2025 - Product Thumbnail Image

Insulin Biosimilars Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Multiple Sclerosis Market in US 2025-2029 - Product Thumbnail Image

Multiple Sclerosis Market in US 2025-2029

  • Report
  • December 2024
  • 139 Pages
  • United States
From
From
Neurology Clinical Trials Market Report 2023-2033 - Product Thumbnail Image

Neurology Clinical Trials Market Report 2023-2033

  • Report
  • January 2023
  • 262 Pages
  • Global
From
From
From
From
From
Stroke Management Market Report 2025 - Product Thumbnail Image

Stroke Management Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Diabetic Neuropathy Market Report 2025 - Product Thumbnail Image

Diabetic Neuropathy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator